Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 13 Feb 2026 for ONCOLYTICS BIOTECH INC, €21k. Read the official filing
Filing timeline
BuySaleWayne Pisano
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -20.0%Entry US$4.05 · Close at T+90 US$3.24
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Wayne Pisano: trading record in brief
Filings by Wayne Pisano span 3 companies, the busiest being Altimmune, Inc., Oncolytics Biotech Inc and Provention Bio, Inc. Between 22 December 2022 and 12 February 2026, the trades on record add up to 4 filings.
The open-market record is one-sided, with 2 purchases worth €39k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 option exercise. In 2026 alone, the filings show 2 purchases and no sales.
On 13 February 2026 came the latest disclosure, an open-market purchase for €21k in Oncolytics Biotech Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Wayne Pisano
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
30,000 shares@ US$0.8446100.0% of flowCommon SharesSEC:0001493152-26-006547:0
Canonical exit: 13 May 2026 (T+90)
5,000 shares@ US$4.08226.3% of flowCommon Stock, par value $0.0001SEC:0001743611-26-000002:0
Canonical exit: 8 Apr 2026 (T+90)
7,500 sharesCommon StockSEC:0001493152-23-013919:0
20,000 shares@ US$2.6073.7% of flowCommon Stock, par value $0.0001SEC:0001104659-22-129514:0
4 of 4 declarations
